Office of Science Policy Mission Statement
The NIH Office of Science Policy (OSP) advises the NIH Director on matters of significance to the agency, the research community, and the public, with an eye toward promoting progress in the biomedical research enterprise through the development of sound and comprehensive policies. Toward that end, OSP:
- Analyzes and fosters discourse about a broad range of scientific, ethical, legal, social, and safety issues;
- Identifies important emerging policy issues that affect biomedical research; and
- Takes into account the concerns of the agency, the scientific community, and the public at large.
OSP’s various offices and programs work on a wide range of issues including biosafety, biosecurity, genetic testing, genomic data sharing, human subjects protections, the organization and management of the NIH, and the outputs and value of NIH-funded research. This is accomplished through a wide range of analyses and reports, commentary on emerging policy proposals, and the development of policy proposals for consideration by NIH, the Federal government, and the public. Broad input from across the government, the scientific community, and the general public is critical to the development of sound policy and the conduct of OSP programs. OSP therefore provides and manages multiple forums for policy input, such as Federal advisory committees, stakeholder consultation meetings, trans-NIH and trans-Federal committees, and broad solicitations of public comment.
Public input on OSP activities is always welcome, and interested members of the public may contact us at SciencePolicy@od.nih.gov
David Shurtleff, Ph.D.
Acting Associate Director for Science Policy
National Institutes of Health